Spinal stimulation helps paralyzed man stand, make step-like movements

The pairing of electrical stimulation of the spinal cord and extensive physical therapy has allowed a man with paralyzed legs to stand and make step-like movements. Conducted by a team of Mayo Clinic researchers and a team led by V. Reggie Edgerton, PhD, of the University of California, Los Angeles, the work was featured in an article published in Mayo Clinic Proceedings.

The 26-year-old man had injured his spinal cord at the sixth thoracic vertebra three years ago. He was diagnosed with a motor complete spinal cord injury, meaning he could not move or feel anything below the middle of his abdomen.

The study began with 22 weeks of intense physical therapy to train the muscles in completing the tasks set by the spinal cord stimulation. Following physical therapy, an electrode was implanted in the patient that sent electrical current to the spinal cord and connected to a computer-controlled device under the patient’s skin.

After three-weeks of recovery, the patient continued physical therapy along with spinal stimulation. After two weeks, the patient was able to control his muscles and move his legs and make step-like movement while lying on his side. He was also able to stand with support.

"We're really excited, because our results went beyond our expectations," said neurosurgeon Kendall Lee, MD, PhD, principal investigator and director of Mayo Clinic's Neural Engineering Laboratory. "These are initial findings, but the patient is continuing to make progress."

"While these are early results, it speaks to how Mayo Clinic researchers relentlessly pursue discoveries and innovative solutions that address the unmet needs of patients," said Gregory Gores, MD, Mayo Clinic's executive dean of research. "These teams highlight Mayo Clinic's unique culture of collaboration, which brings together scientists and physician experts who work side by side to accelerate scientific discoveries into critical advances for patient care."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.